Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections.
about
Update on surgical treatment of pancreatic neuroendocrine neoplasmsClinical outcomes and prognostic factors of resected pancreatic neuroendocrine neoplasms: A single-center experience in ChinaMinimally invasive distal pancreatectomy for PNETs: laparoscopic or robotic approach?Loss of 11p11 is a frequent and early event in sporadic nonfunctioning pancreatic neuroendocrine neoplasms.Clinicopathological features of small nonfunctioning pancreatic neuroendocrine tumorsOverestimated Oncologic Significance of Lymph Node Metastasis in G1 Nonfunctioning Neuroendocrine Tumor in the Left Side of the Pancreas.Lymph nodes and survival in pancreatic neuroendocrine tumors.Postoperative Complications, In-Hospital Mortality and 5-Year Survival After Surgical Resection for Patients with a Pancreatic Neuroendocrine Tumor: A Systematic Review.ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.Clinical presentation, recurrence, and survival in patients with neuroendocrine tumors: results from a prospective institutional database.Impact of 68Ga-DOTATATE PET/CT on the management of neuroendocrine tumors: the referring physician's perspectiveTreatment of malignant pancreatic neuroendocrine neoplasms: middle-term (2-year) outcomes of a prospective observational multicentre study.Review article: the investigation and management of gastric neuroendocrine tumours.The 2010 WHO classification of digestive neuroendocrine neoplasms: a critical appraisal four years after its introduction.Clinical, pathological, and demographic factors associated with development of recurrences after surgical resection in elderly patients with neuroendocrine tumors.Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives.Outcomes of Pancreaticoduodenectomy for Pancreatic Neuroendocrine Tumors: Are Combined Procedures Justified?DAXX/ATRX and MEN1 genes are strong prognostic markers in pancreatic neuroendocrine tumors.Long-term outcome of laparoscopic surgery for pancreatic neuroendocrine tumors.Lymph node ratio, but not the total number of examined lymph nodes or lymph node metastasis, is a predictor of overall survival for pancreatic neuroendocrine neoplasms after surgical resection.Pancreatic neuroendocrine tumors: accurate grading with Ki-67 index on fine-needle aspiration specimens using the WHO 2010/ENETS criteria.Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification.Basing treatment strategy for non-functional pancreatic neuroendocrine tumors on tumor size.Intrinsic Contact Between T and N Classifications in Resected Well-Moderately Differentiated Locoregional Pancreatic Neuroendocrine Neoplasms.Nomogram predicting the risk of recurrence after curative-intent resection of primary non-metastatic gastrointestinal neuroendocrine tumors: An analysis of the U.S. Neuroendocrine Tumor Study Group.A Lymph Node Ratio-Based Staging Model Is Superior to the Current Staging System for Pancreatic Neuroendocrine Tumors.How reliable is the Ki-67 cytological index in grading pancreatic neuroendocrine tumors? A meta-analysis.Surgical resection of neuroendocrine tumors of the pancreas (pNETs) by minimally invasive surgery: the laparoscopic approach.Surgical treatment of sporadic pancreatic neuroendocrine tumors: a state of the art review.Ki-67 cytological index can distinguish well-differentiated from poorly differentiated pancreatic neuroendocrine tumors: a comparative cytohistological study of 53 cases
P2860
Q26864361-8DFF4664-9C8E-4F3B-91AF-67DA5BC9F6DEQ33684746-E0E92754-3F44-4FE8-AC86-F7E6C3ABAC34Q33779718-B180F68C-8231-4E4E-846C-91A75DD5FAAEQ34000638-272071E6-D9FF-4945-A1BE-DF8C00BCDEAFQ34750730-537025A7-295A-499B-9B06-31C87DB8DDC4Q36194989-D2D6DE70-DF1B-4686-B1F1-4F3274A16CBDQ36250472-7CCF62D1-F48D-4B86-9946-8D482616FFC5Q36558853-AA95A918-70F0-4CDA-9CB0-6CE311F6F3D8Q36849357-E036FE74-4C58-4718-9885-062B2EEC9E33Q37085554-5F29A57A-D9E9-428E-9DCF-0AFE326040F6Q37347947-87B21B2C-A7BB-48DA-932A-60AF45F69E5EQ37350299-4FC17DE8-6A0C-4186-9684-1CB7432FE5DCQ38195905-D451CA1B-673D-4ADA-8CF8-B71DE35AEBE6Q38202029-4FBD3263-D05F-4942-BFDC-51F131241BDAQ38690778-471BF097-9A15-4F36-9E57-6F97E8A22F99Q38730927-E40F0EC4-F047-4DFB-AB3A-13F02B179D63Q38754421-23ACFDC7-2975-4C51-9677-A303E15F581AQ41472752-510BC056-38C8-4E04-A6E2-3CA8EB9AF0CCQ44435779-E3776D10-385F-49F5-AD6C-5148706F000CQ45902785-D5EDE772-0843-494D-B4B0-C08597F12402Q45999443-B9E3C221-2914-44E0-8D84-31E220E48A81Q46945283-20E7C811-3F1A-42A1-95A0-F88AD16FCD48Q47175334-ABADD94D-B2AC-449A-B173-D52F2658EB5EQ47194441-08BBEB92-14EF-42A1-8634-C19C853D5DF4Q49966883-CF6DBDA1-DD4A-491D-81F5-6B46F2198D57Q50082628-6A3D9882-DD15-4F24-9A2D-916C017A9B0AQ53227607-5478541A-5EBD-4B21-8103-5D9824B18EC4Q53415537-A0342D98-B1CF-46C4-A56B-AD765752E2CAQ55192213-69C64B89-0662-4C05-AE07-3C9D5F85EF4CQ57972622-C2C0909D-9223-4215-9C19-20F64489E27A
P2860
Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Malignant pancreatic neuroendo ...... nce after curative resections.
@en
Malignant pancreatic neuroendo ...... nce after curative resections.
@nl
type
label
Malignant pancreatic neuroendo ...... nce after curative resections.
@en
Malignant pancreatic neuroendo ...... nce after curative resections.
@nl
prefLabel
Malignant pancreatic neuroendo ...... nce after curative resections.
@en
Malignant pancreatic neuroendo ...... nce after curative resections.
@nl
P2093
P50
P1476
Malignant pancreatic neuroendo ...... nce after curative resections.
@en
P2093
Gianfranco Delle Fave
Letizia Boninsegna
Paola Capelli
Paolo Pederzoli
Rossella Bettini
P304
P356
10.1016/J.EJCA.2011.10.030
P577
2011-11-28T00:00:00Z